Citing lingering concerns, FDA stops Evoke at the 10-yard line a month before PDUFA date
It took Evoke Pharma two years and a couple rounds of fundraising to slice and pull the data for an NDA of its only drug …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
